Introduction
Tuberculosis incidence, prevalence and mortality trends have been declining over the last decade, but the target of halving the 1990 prevalence rate by 2015 established by the Stop TB partnership will probably be missed. The new post-2015 Global TB Strategy aims at a 95% mortality reduction compared with 2015 slave. To accomplish these objectives it will be necessary, among other things, to encourage intensified research and innovation. 1 It is unknown which immunological parameters can be used to predict who will control the infection by Mycobacterium tuberculosis and who will develop clinical disease. 2 Methodologies used to characterize the immunology of infectious diseases include the experimental infection of either animals or isolated immune cells and, less frequently, whole blood-an alternative model already described in classical studies. 3 Advantages of the blood model include its use without further manipulation, which minimizes cellular activation, and the interaction of both humoral and cellular components. Currently, this model serves in tuberculosis research two main purposes. One is the analysis of the antimycobacterial activity in relevant groups like individuals infected with M. tuberculosis, 4 vaccinated 5, 6 or infected with HIV. 7, 8 In these studies the usual finding is that blood from healthy or vaccinated people is more bactericidal than blood from patients. The second main purpose is the evaluation of the effect of antibiotics against intracellular mycobacteria, as an alternative to the use of isolated bacteria. [9] [10] [11] Other reports were concerned with the susceptibility of different M. tuberculosis strains to the mycobactericidal power of blood 12, 13 or the effect of treatments like the addition of TNF-a blockers. 14 We have hypothesized that the susceptibility of groups that are at increased risk of tuberculosis disease would be detected by testing the antimycobacterial activity of whole blood. 15 We have recently reported that macrophages from elders are more permissive to intracellular growth of M. tuberculosis. 16 We have tried to reproduce this finding in whole blood, but the results were negative. We have reasoned that the participation of blood components other than monocytes might account for this inconsistency.
Materials and methods

Bacterial strains
M. tuberculosis HL186T and Mycobacterium gordonae HL184G were isolated at the Hospital Universitario de Leo´n. They were grown on 7H11 agar and were individualized and frozen as described elsewhere. 16 Legionella pneumophila Philadelphia (ATCC 13151) was grown on buffered charcoal yeast extract agar plates (BCYE). Escherichia coli (CECT 568, that corresponds to ATCC 13027), kindly provided by Dr Leandro Rodrı´guez, was grown on Luria agar (LA) plates. Single-use aliquots of all the bacteria suspended in RPMI-1640 medium with 25 mM HEPES (HyClone, Thermo Scientific, Waltham, MA USA) were stored at À80 C.
Blood fractionation
The informed consent and protocol were approved by the institutional review board at the Hospital Universitario de Leo´n (Clinical Research Ethics Board). All subjects gave written informed consent. Peripheral blood was collected from healthy volunteers in BD Vacutainer Blood Collection Tubes (Becton Dickinson, Franklin Lakes, NJ, USA) with either a clot activator or a coagulation inhibitor (K 3 EDTA). All procedures were performed at room temperature.
Plasma was obtained by centrifugation of anticoagulated blood at 500 g for 10 min and subsequent centrifugation of the supernatant at 1300 g for 5 min. Leukocytes, erythrocytes and platelets were separated from blood and suspended in RPMI-1640 using the same volume than that of blood from which they were isolated. Leukocytes were isolated after two rounds of hemolysis with water (1 volume blood: 10 volumes water) for 30 s, equilibration with concentrated PBS (Â10) and centrifugation at 1300 g for 5 min. Erythrocytes were purified by dextran sedimentation to avoid neutrophil contamination and then washed twice with PBS and once with RPMI-1640 medium. For platelet isolation blood was centrifuged at 200 g for 10 min, supernatant was recovered and mixed with RPMI-1640 medium (1:1 volumes). Diluted supernatant was centrifuged first at 100 g for 5 min to remove remaining leukocytes, recovered and centrifuged again at 800 g for 15 min. The pellet after this centrifugation was formed by platelets.
When the whole cellular fraction (leukocytes + erythrocytes) was needed, a volume of whole blood was washed twice with 2.5 volumes of PBS (1300 g, 5 min). Assuming that the cellular fraction is approximately half the volume of blood, 0.5 volumes of either plasma or serum were added to the pellet to restore the cellular concentration. For the purification of monocytes, mononuclear cells were isolated by Ficoll-Paque Plus density gradient sedimentation (GE Healthcare, Little Chalfont, UK), and CD14 + cells (monocytes) were obtained by magnetic cell separation (Miltenyi Biotec, Bergisch Gladbach, Germany). Some cells were activated with 25 ng/ml IFN-g (! 2 Â 10 7 units/mg; Peprotech, London, UK).
In vitro infection
Infections (5 Â 10 5 bacteria/ml) were performed in 40% of either whole blood or blood fractions. Volume was adjusted to 300 ml in 2-ml tubes with RPMI-1640 medium. Incubations were carried out in a rotary shaker at 37 C for 2 d, unless otherwise indicated. For analysis of mycobacterial survival 10 ml was diluted in 390 ml water and incubated for 2 min to lyse cells, followed by addition of 50 ml Middlebrook enrichment supplement ADC (albumin, dextrose, catalase; Becton Dickinson Microbiology Systems, Franklin Lakes, NJ USA) and 50 ml concentrated 7H9 medium (Â10) with 2% glycerol. Decimal dilutions were inoculated into 96-well plates and incubated at 37 C for 7 d. Colonyforming units (CFU) were counted under an inverted microscope at Â 100 magnification. 17 For both L. pneumophila and E. coli 10 ml was diluted in 490 ml water and decimal dilutions were inoculated and incubated for 3 d in BCYE and overnight in LA plates,
respectively. Leukocytes in the presence of plasma were no longer in suspension because they formed loose cellular aggregates. To release intracellular bacteria within these aggregates the samples were sonicated with a Branson S-450 digital ultrasonic cell disruptor microtip (Branson Ultrasonics, Danbury, CT USA), at an amplitude of 10% (2 W) for 3 s. For monocyte infection, 10 5 monocytes per well were seeded in 96-well plates and infected with 2 Â 10 5 bacteria and incubated at 37 C in 95% air/5% CO 2 for the indicated periods of time. Extracellular bacteria were not washed. Infected cells were lysed by sonication as described above. Decimal dilutions of the lysates in complete 7H9 medium were incubated in 96-well microplates and CFU enumerated as described above. Micrographs of the infected monocytes were taken in an inverted DMIL phase microscope (Leica, Wetzlar, Germany) equipped with an AM4023X DinoEye Eyepiece Camera (DinoLite, New Taipei City, Taiwan), magnification Â 400.
Phagocytosis assay
For detection of bacteria by flow cytometry M. gordonae was transformed with the expression plasmid pMDsRed containing the gene of the fluorescent protein DsRed.T3_S4T, and constructed as described elsewhere. 16 Flow cytometry with M. tuberculosis was precluded for biosafety reasons. Forty percent blood in RPMI-1640 medium was pre-incubated with or without cytochalasin D (10 mg/ml; StressMarq Biosciences, Cadboro Bay, Canada) for 1 h, infected with 5 Â 10 5 bacteria/ml and incubated for 2 additional h in a rotary shaker at 37 C. Cell lineages (monocyte, neutrophils and erythrocytes) were stained with appropriate mAbs conjugated directly to fluorochromes: fluorescein isothiocyanate-conjugated anti-CD66b (for neutrophils), peridinin chlorophyll-protein complex (PerCP)conjugated anti-CD14 (for monocytes; Becton Dickinson, Franklin Lakes, NJ, USA) and PerCP-Vio700-conjugated anti-CD235a (for erythrocytes; Miltenyi Biotec). Data acquisition and analysis were performed on a FACScan flow cytometer using CellQuest software (Becton Dickinson).
Statistical analysis
Two group comparisons of normally distributed data (Shapiro-Wilk test) were performed by paired Student's t-test. Comparisons between more than two groups were performed by one-way ANOVA with the Games-Howell post-hoc test because variances were not homogeneous. The statistical program used was PASW Statistics 18 (IBM, Armonk, NY, USA). Factorial designs are characterized by the investigation in each replication of all the possible combinations of the levels of the factors. They are more efficient than one-factor-at-a-time designs like ANOVA, because in a single experiment we obtain several estimates for every factor, and a smaller sample size is required. 18 We used a two-level factorial design for four factors, and we needed to perform 2 4 infections per sample plus two additional central points, obtained by adding half the amount of each of the factors combined. Results were analysed with Design-Expert 9.0.3.1 (Stat-Ease, Minneapolis, MN, USA). In all statistical analysis, a P-value < 0.05 was considered significant.
Results
Antimycobacterial activity is similar in blood from both elders and young adults
Macrophages from elders have been described to allow higher M. tuberculosis intracellular multiplication. 16 Consequently, we determined to study if we could reproduce these results using whole blood in order to develop a simple in vitro assay that may predict the tuberculosis susceptibility of an individual. As several studies had described before, 6, 9, 10, 12, 13 we found that blood exhibited mycobactericidal activity. But, to our surprise, the median number of surviving bacteria after 4 d of infection was nearly identical in elders and young adults groups [median log 10 CFU (interquartile range); elders 5.01 (0.47) (n ¼ 25); young adults: 5.02 (0.48)
To simplify the assay we studied whether we could incubate the infected blood for fewer days. After 6 d 99.8% of the bacteria were eliminated, but much of the killing occurred during the first 3 d (70.5% the first day, 83.4% the second and 92.6% the third). It was decided for the rest of experiments to infect blood for 2 d.
Blood leukocytes from healthy people do not kill M. tuberculosis
It is generally assumed that mycobacterial killing in whole blood is accomplished by leukocytes. Therefore, we isolated and infected them with M. tuberculosis and M. gordonae, a non-pathogenic mycobacterium that we have previously shown to resist the antimicrobial activity of human macrophages and neutrophils. 19 As a comparison control we also included another non-mycobacterial intracellular pulmonary pathogen, L. pneumophila, which is killed by IFN-g activated monocytes. 19 To suspend the cells we used either serum, the most common supplement for in vitro infections, or plasma, which resembles more closely physiological conditions. We observed that leukocytes were not able to eliminate M. tuberculosis. In contrast, M. gordonae was killed by leukocytes in both serum and plasma. The L. pneumophila control was efficiently killed by leukocytes in plasma ( Figure 1a ), which shows that leukocytes display antimicrobial activity against susceptible microorganisms.
The main cellular target of these pathogens are the macrophages, which strongly attach to the plastic of cell culture plates. To determine whether the characteristic antimicrobial activity displayed by macrophages activated with IFN-g in plates against L. pneumophila 20 was also exhibited by cells in suspension we infected monocytes in the usual supplement-serum-and incubated them in a rotary shaker. We confirmed in the dynamic culture that activated monocytes could eliminate L. pneumophila but not M. tuberculosis (Figure 1b ).
A similar result was observed for the leukocyte fraction of blood, but it was not statistically significant (P ¼ 0.076), probably because bacteria are also phagocytosed by neutrophils. From this experiment we conclude that isolated leukocytes infected in a dynamic culture reproduce similar results to those usually obtained for purified monocytes activated with IFN-g.
Plasma contributes to the antimycobacterial activity detected in whole blood
These results prompted us to assess the effect of excluding the blood cellular fraction. To test the antimicrobial activity of serum we used as a control E. coli because it has been described as serum sensitive. 21 Serum did not exhibit antimicrobial activity against M. tuberculosis, but there was a significant killing in plasma. Nevertheless, the smallest number of surviving bacteria was obtained in whole blood (Figure 2a ). A very similar pattern of bacterial killing was observed for M. gordonae but, in this case, the bacteria were also sensitive to serum. For L. pneumophila results were similar but accentuated. In sharp contrast, E. coli was not eliminated by whole blood but was sensitive to plasma and to a higher degree, serum, demonstrating that the antimicrobial activity of serum was not altered.
Results for M. tuberculosis were further supported in an additional experiment ( Figure 2b) . The cellular fraction of blood was washed in PBS and pelleted. Twenty percent of the original blood volume was reconstituted with 20% of either plasma o serum and 60% of RPMI-1640. The number of viable bacteria in blood cells with serum did not change after 2 d with respect to the inoculum. In contrast, the bacterial killing in blood cells with plasma was similar to the unwashed blood (40% in RPMI-1640 medium). These observations confirmed that plasma, but not serum, had anti-M. tuberculosis activity.
To further characterize the activity of plasma against M. tuberculosis we incubated in a dynamic culture the bacilli in the presence of plasma and enumerated the surviving bacteria for several d (Figure 2c ). We observed that the activity of plasma was slow, and parallel to that of blood. It took 5 d to reduce the number of viable bacteria more than 1 log 10 unit, but after 7 d it was reduced by 4 log 10 units. In contrast, antimycobacterial activity in whole blood is more dramatic after 5 d.
We also addressed the important question of the amount of plasma needed to show full mycobactericidal activity. For this purpose we incubated in 96-well plates the bacteria in liquid medium (supplemented 7H9) in the presence of increasing amounts of plasma and, surprisingly, we found that between 5% and 10% of plasma was enough to kill M. tuberculosis (Figure 2d ). These observations may offer an explanation for the lack of differences on the antimycobacterial activity exhibited by blood from either young individuals 
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or elders. Although it has been previously observed that the bacilli have a higher growth rate in the macrophages of elders, 16 in blood the bactericidal activity is displayed by plasma, which seems to have a comparable antimycobacterial activity in both groups. Because cells did not seem to exhibit antimycobacterial activity we speculated whether they were used as safe havens by M. tuberculosis to avoid the exposition to the antimicrobial activity of plasma. To test this hypothesis, we inhibited phagocytosis by adding cytochalasin D. We observed that a significant lower proportion of either monocytes or neutrophils were infected by M. gordonae in the presence of the inhibitor (Figure 3a) . The phagocytosis restrain allowed the exposure of M. gordonae to antimicrobial mechanisms (paired Student's t-test, P ¼ 0.037) but, unexpectedly, had no effect on M. tuberculosis (Figure 3b ).
Finally, to analyze the influence of plasma or serum on isolated monocyte derived macrophages we performed the standard infection protocol in 96-well plates with two M. tuberculosis bacteria per monocyte. In plasma the effect was bacteriostatic, while in serum bacteria kept growing for several d (Figure 4a ). Intracellular multiplication of bacilli was readily observed in macrophages incubated in serum and stained by the Kinyoun method (Supplementary Figure S1 ). We attribute the exponential growth in serum to both intra-and extracellular multiplication after the release of intracellular bacteria from necrotic macrophages because the cell layer was almost (Figure 4b ). Macrophages in plasma were also affected but no extracellular growth could be detected. In fact, the number of bacteria after 6 d was not significantly different from the day of inoculation (paired Student's t-test, P ¼ 0.104), suggesting that macrophages inhibit M. tuberculosis growth in the presence of plasma. This experiment shows that the effect of plasma is also visible in infected monocytes attached to plastic and reproduces the already described intracellular growth of M. tuberculosis in serum, the traditional supplement used for the culture of monocytes. 22 This result differs from the infection of leukocytes (Figure 1a ), because no growth of M. tuberculosis could be detected in infected leukocytes incubated in serum. We do not know the reason, but it may be related to the fact that relatively few bacteria are phagocytosed by monocytes, which are normally < 10% of total leukocytes. Macrophages are the main cellular target of M. tuberculosis, and a pure culture of monocyte-derived macrophages may favor intracellular multiplication.
Erythrocytes cooperate in the bactericidal power of blood
Results in Figure 2a showed that plasma did not reach the bactericidal power of whole blood, which suggests that other blood components complemented its antimicrobial activity. With no evidence of the leukocytes participation, only erythrocytes and platelets were left as candidates. To study their influence we designed a 2 n factorial experiment with four factors (2 4 ): leukocytes, plasma, platelets and erythrocytes. In the factor combinations in which plasma was not present we (Figure  2a ), instead of RPMI-1640 medium. As expected, plasma had a very highly significant effect and it was confirmed the lack of influence of leukocytes (Table 1) . Platelets did not have an apparent effect but, interestingly, erythrocytes had a large influence. Furthermore, interactions of erythrocytes with plasma and leukocytes were also statistically significant. To verify these results we performed a new experiment with an independent sample using a 'one-factor-at-a-time' design. We replicated for blood and plasma previous results for M. tuberculosis and M. gordonae (Figure 2a ), and we confirmed the erythrocyte mycobactericidal activity, which was increased upon plasma addition (Figure 5a ). We analyzed in further detail the interaction between erythrocytes and mycobacteria and observed that a small proportion of erythrocytes (CD235a + ) physically associated with M. gordonae, although in this assay it may not be established the nature of the interaction, binding and/or internalization (Figure 5b) . Nevertheless, we realized that infected erythrocytes were hemolysed. Supernatants in non-infected erythrocytes were transparent after an incubation of 2 h. In contrast, supernatants from erythrocytes infected with different bacteria were red as a result of hemolysis (Figure 5c ).
Discussion
Studies of contacts in tuberculosis have shown that in roughly 50% of them there is no conversion in the tuberculin skin test, 23 although it may be expected that many of them were exposed to M. tuberculosis. These findings show that a large proportion of individuals have some level of resistance, which is strong in some heavily exposed contacts that get rid of the bacterium before an adaptive response develops, a phenomenon described as 'early clearance'. 24 Nevertheless, the immunological bases of their resistance are not known. The immune response to M. tuberculosis has been classically considered as cellular, with an unclear participation of the humoral immunity. 25 We were able to obtain a mycobactericidal activity with a combination of plasma and erythrocytes similar to that of whole blood. In fact, it should not be surprising that leukocytes isolated by hypotonic shock 
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from blood do not exhibit antimycobacterial activity, because that is the common result that has been obtained for decades by most research groups when using either purified monocytes or neutrophils. 22 Accordingly, it may be necessary to reconsider the general assumption that antimycobacterial activity detected in whole blood is largely cell mediated. 4, 9, 26 Because we worked with healthy volunteers we find it likely that cellular immunity may only be detected in the blood from individuals that have developed an adaptive immunity. Little attention has been paid to the role of plasma in antimycobacterial activity. This may be a consequence of the generalized use of serum for in vitro infection experiments. Our results (Figure 4a ) are in line with those of Vogt and Nathan obtained using plasma instead of FBS for the culture of monocyte-derived macrophages, which allowed a restriction of M. tuberculosis multiplication. 27 The few articles that have described the analysis of plasma have reported variable outcomes. Al-Attiyah et al. 12 used a luciferase reporter construct of M. tuberculosis H37Rv, and showed that the amount of luminescence decreased after culturing the bacteria in plasma. They interpreted this pattern as a failure to grow in plasma. 27 Under the light of our results it is possible that they were actually detecting a killing activity. In a study by Eisen et al. 26 the mycobacterial growth in whole blood, plasma and mycobacterial culture broth were compared at different altitudes, also using a luciferase reporter construct, in this case of bacillus Calmette-Gue´rin (BCG). They show that at low altitude there is a decrease in plasma of 0.55 log 10 units of luminescence. Again, the interpretation was that mycobacterial growth in plasma is minimal when, probably, they were also detecting antimycobacterial activity. Interestingly, they found that at high altitude the mycobacteria grew in plasma. They argued that 'plasma has long been known to be tuberculostatic, neither supporting TB growth nor killing TB'. We have tried unsuccessfully to find evidence in the literature that support this view. Surprisingly, in the reference that they use to justify this affirmation there is no allusion to plasma. In another study in which antimicrobial activity was quantified by enumerating CFU it was also found that the number of bacteria decreased in plasma after 24 h. 28 Finally, in a study by Kampmann et al. 4 the investigators seemed to use the same reporter construct that Eisen et al., 26 but found that BCG grew in plasma. At this moment we do not know the reasons for this disparity, but it may depend on the technical conditions of the assay. Indeed, as we indicated above, Eisen et al. 26 detected growth of the bacterium at high altitude. The reporter construct seems to be the same that Al-Attiyah et al. 12 used in M. tuberculosis H37Rv. These results highlight an influence of bacterial strains that has already been remarked in other studies. 13, 29 Janulionis et al. 13 showed that some clinical strains were more sensitive and some more resistant to blood than H37Rv. Accordingly, we thought that it was more appropriate to use a clinical isolate that had recently caused disease.
Most of the studies regarding the antimicrobial activity of humoral factors in blood have been performed using serum. 21 We find most intriguing the different biological effect for M. tuberculosis that has serum in comparison with plasma. The reasons may deal with the fact that the coagulation activates several proteases that may hydrolyze antimicrobial proteins or that relevant molecules may be specifically sequestered in the clot. It is also possible that differences in the antimicrobial activity of blood, plasma or serum are related to variations in the content of nutrients in each of these biological fluids. For example, proteomic analysis has revealed significant differences in the protein composition of serum and plasma. 30 Nevertheless, we do not think that lack of nutrients in plasma is critical for explaining the killing of mycobacteria because M. tuberculosis does not survive in 7H9 bacterial medium supplemented with 10% plasma (Figure 2d ). At this point we do not know the biological basis of the difference in the antimicrobial activity.
A final finding has been the direct participation of erythrocytes in the antimycobacterial activity. Researches have concluded that mycobacteria undergo nearly complete phagocytosis in blood because they were not found in the supernatants of infected blood centrifuged at low speed, 6,9 but we have shown that some associate to erythrocytes (Figure 5b) .The interaction of microorganisms to red cells has been long known, 31 and it has been observed that some species invade these cells. 32, 33 We showed that erythrocytes have antimycobacterial activity but were more effective in combination with plasma. At this point we do not know the responsible bactericidal mechanism, but several options have been described. It has been suggested that iron, abundantly present in erythrocytes, may influence the activity against Streptococcus pneumoniae in blood. 33 It has also been described that peptides from hemoglobin origin (hemocidins) have antibacterial properties. 34 The question about the role of leukocytes in healthy volunteers remains unanswered. The experiment of M. gordonae phagocytosis inhibition showed that it allowed a more efficient elimination (Figure 3) , which may indicate that leukocytes could serve as safe havens, as has long been suggested for other bacteria. 35 The negative results with M. tuberculosis were puzzling, although we did not test the influence of cytochalasin D on M. tuberculosis phagocytosis.
In conclusion, we have found that in blood from healthy volunteers the antimycobacterial activity was exerted mainly by plasma and erythrocytes, and that leukocytes did not seem to participate. Some evidence regarding plasma was already present in the literature,
but seems to have been overlooked, possibly owing to the strong influence that the cellular response has over our conceptions about the immunology of tuberculosis. There is little doubt that for infected individuals that have developed an adaptive response the cellular immunity is critical, and responsible for the successful control of tuberculosis in 90% of the cases. But the characteristics of this protective response are elusive. The 'central dogma' says that IFN-g production by CD4 + T cells is the major driver of immunity to tuberculosis, but the intricacies of immunity to M. tuberculosis require that we reassess its role. 2 We do not know the immunological basis of tuberculosis resistance in those that exhibit an 'early clearance' of the pathogen, although they represent a substantial proportion of infected people. 24 As would be expected, it has been assumed that is cell mediated, but our results are compatible with a different interpretation. We propose that the humoral response may have much more importance in the initial protection than previously acknowledged. Although the influence of Abs is being increasingly recognized, 36 we do not anticipate them to be present in many of the resistant individuals that exhibit 'early clearance'. We rather think that the molecules involved in protection might be antimicrobial proteins or peptides that are constitutively expressed in plasma, 37 and the difference in their quantity and type of molecules is what may determine the level of innate resistance. If this hypothesis was correct, the whole blood model might be appropriate for its study because many of the plasma molecules are also present in the lungs. 38 In fact, several of these molecules have tuberculocidal activity, and they may have practical importance as targets for host-directed therapies. 39 Molecules found in blood that are also expressed in the lung include lysozyme, defensins, LL-37 or CCL20. 38 They are synthesized in the lung mainly in the airway epithelium, 40 and also by immune cells recruited from blood. 38 Nevertheless, the cellular and humoral innate immunity is different in the bronchoalveolar spaces compared with peripheral blood. The composition of immune cells changes dramatically in both tissues. In blood there is <10% of monocytes and > 50% of neutrophils, while bronchoalveolar cells are mostly macrophages (>90%) with few neutrophils (<1%). There are several other differences, like the expression of TLRs, which varies between alveolar macrophages and blood monocytes, or the expression of collectins in the lung. 41 In any case, the blood antimicrobial activity seems to be similar in both young individuals and elders, although their macrophages respond differently to a M. tuberculosis infection. 16 Our results support the idea that susceptibility to tuberculosis may have both cellular and humoral components. The utility of blood or even only plasma as infection models for studying tuberculosis susceptibility in other risk groups warrants further investigation.
